Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) versus alemtuzumab in multiple sclerosis: Systematic review and individual patient data meta-analysis.

AHSCT may be associated with improved inflammatory disease control and disability recovery compared with alemtuzumab in highly active MS, and should be interpreted as hypothesis-generating, given the very low certainty of the evidence and the reliance on observational data.

Naima Kebir, Salem Waleed, Yousef El Sayed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.